These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33016238)

  • 1. A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple Sclerosis.
    Matza LS; Phillips G; Dewitt B; Stewart KD; Cella D; Feeny D; Hanmer J; Miller DM; Revicki DA
    Med Decis Making; 2020 Oct; 40(7):897-911. PubMed ID: 33016238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models.
    Ahmad H; Campbell JA; van der Mei I; Taylor BV; Xia Q; Zhao T; Palmer AJ
    Qual Life Res; 2023 Dec; 32(12):3373-3387. PubMed ID: 37522942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using existing data to identify candidate items for a health state classification system in multiple sclerosis.
    Kuspinar A; Finch L; Pickard S; Mayo NE
    Qual Life Res; 2014 Jun; 23(5):1445-57. PubMed ID: 24338161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
    Kuspinar A; Mayo NE
    Health Qual Life Outcomes; 2013 Apr; 11():71. PubMed ID: 23618072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deriving a Preference-Based Measure for People With Duchenne Muscular Dystrophy From the DMD-QoL.
    Rowen D; Powell P; Mukuria C; Carlton J; Norman R; Brazier J
    Value Health; 2021 Oct; 24(10):1499-1510. PubMed ID: 34593174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using EQ-5D to derive general population-based utilities for the quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA).
    Kołtowska-Häggström M; Jonsson B; Isacson D; Bingefors K
    Value Health; 2007; 10(1):73-81. PubMed ID: 17261118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module.
    Cuervo J; Castejón N; Khalaf KM; Waweru C; Globe D; Patrick DL
    Health Qual Life Outcomes; 2014 Oct; 12():147. PubMed ID: 25288099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiattribute health utility scoring for the computerized adaptive measure CAT-5D-QOL was developed and validated.
    Kopec JA; Sayre EC; Rogers P; Davis AM; Badley EM; Anis AH; Abrahamowicz M; Russell L; Rahman MM; Esdaile JM
    J Clin Epidemiol; 2015 Oct; 68(10):1213-20.e1-6. PubMed ID: 25990544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric evaluation of the pediatric and parent-proxy Patient-Reported Outcomes Measurement Information System and the Neurology and Traumatic Brain Injury Quality of Life measurement item banks in pediatric traumatic brain injury.
    Bertisch H; Rivara FP; Kisala PA; Wang J; Yeates KO; Durbin D; Zonfrillo MR; Bell MJ; Temkin N; Tulsky DS
    Qual Life Res; 2017 Jul; 26(7):1887-1899. PubMed ID: 28271316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing.
    Gershon RC; Lai JS; Bode R; Choi S; Moy C; Bleck T; Miller D; Peterman A; Cella D
    Qual Life Res; 2012 Apr; 21(3):475-86. PubMed ID: 21874314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Calibration of the TBI-QOL Ability to Participate in Social Roles and Activities and TBI-QOL Satisfaction With Social Roles and Activities Item Banks and Short Forms.
    Heinemann AW; Kisala PA; Boulton AJ; Sherer M; Sander AM; Chiaravalloti N; Bushnik T; Hanks R; Roth E; Tulsky DS
    Arch Phys Med Rehabil; 2020 Jan; 101(1):20-32. PubMed ID: 31473208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a cross-cultural item bank for measuring quality of life related to mental health in multiple sclerosis patients.
    Michel P; Auquier P; Baumstarck K; Pelletier J; Loundou A; Ghattas B; Boyer L
    Qual Life Res; 2015 Sep; 24(9):2261-71. PubMed ID: 25712324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D.
    Fogarty E; Walsh C; Adams R; McGuigan C; Barry M; Tubridy N
    Mult Scler; 2013 Aug; 19(9):1190-6. PubMed ID: 23401128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI).
    Matza LS; Brazier JE; Stewart KD; Pinto L; Bender RH; Kircik L; Jordan J; Kim KJ; Mutebi A; Viswanathan HN; Menter A
    J Med Econ; 2019 Sep; 22(9):936-944. PubMed ID: 31161828
    [No Abstract]   [Full Text] [Related]  

  • 17. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis.
    Miller DM; Bethoux F; Victorson D; Nowinski CJ; Buono S; Lai JS; Wortman K; Burns JL; Moy C; Cella D
    Mult Scler; 2016 May; 22(6):830-41. PubMed ID: 26238464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional validation of the PROMIS-Preference scoring system.
    Hanmer J; Dewitt B; Yu L; Tsevat J; Roberts M; Revicki D; Pilkonis PA; Hess R; Hays RD; Fischhoff B; Feeny D; Condon D; Cella D
    PLoS One; 2018; 13(7):e0201093. PubMed ID: 30063733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life and utilities among Lebanese patients with Multiple Sclerosis: A cross-sectional study.
    Dahham J; Hiligsmann M; Kremer I; Khoury SJ; Darwish H; Hosseini H; Hallit S; Evers S; Rizk R
    Mult Scler Relat Disord; 2024 Jun; 86():105635. PubMed ID: 38640585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.